Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20002629HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20019180HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20059732HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20059954HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20068180HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20060061HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20027263HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20059257HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20036596HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TVIS20059580HPVENSG00000155511.19protein_codingGRIA1NoNo2890P42261
TCGA Plot Options
Drug Information
GeneGRIA1
DrugBank IDDB09289
Drug NameTianeptine
Target IDBE0000640
UniProt IDP42261
Regulation Typemodulator
PubMed IDs19704408
CitationsMcEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E: The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry. 2010 Mar;15(3):237-49. doi: 10.1038/mp.2009.80. Epub 2009 Aug 25.
GroupsInvestigational
Direct ClassificationMedium-chain fatty acids
SMILESCN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O
Pathways
PharmGKB
ChEMBLCHEMBL1289110